Notes
2011 euros
Reference
Joensuu JT, et al. Cost-effectiveness of biological compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study. Rheumatology : 27 Jun 2016. Available from: URL: http://doi.org/10.1093/rheumatology/kew264
Rights and permissions
About this article
Cite this article
Biological DMARDs not cost effective for RA in Finland. PharmacoEcon Outcomes News 757, 6 (2016). https://doi.org/10.1007/s40274-016-3195-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3195-x